PMID- 23814473 OWN - NLM STAT- MEDLINE DCOM- 20140203 LR - 20211021 IS - 1976-555X (Electronic) IS - 1229-845X (Print) IS - 1229-845X (Linking) VI - 14 IP - 2 DP - 2013 TI - Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis. PG - 199-205 LID - 10.4142/jvs.2013.14.2.199 [doi] AB - In humans, skin barrier dysfunction is thought to be responsible for enhanced penetration of allergens. Similar to conditions seen in humans, canine atopic dermatitis (CAD) is characterized by derangement of corneocytes and disorganization of intercellular lipids in the stratum corenum (SC) with decreased ceramide levels. This study was designed to evaluate the effects of a moisturizer containing ceramide on dogs with CAD. Dogs (n = 20, 3~8 years old) with mild to moderate clinical signs were recruited and applied a moisturizer containing ceramide for 4 weeks. Transepidermal water loss (TEWL), skin hydration, pruritus index for canine atopic dermatitis (PICAD) scores, and canine atopic dermatitis extent and severity index (CADESI) scores of all dogs were evaluated. Skin samples from five dogs were also examined with transmission electron microscopy (TEM) using ruthenium tetroxide. TEWL, PICAD, and CADESI values decreased (p < 0.05) and skin hydration increased dramatically over time (p < 0.05). Electron micrographs showed that the skin barrier of all five dogs was partially restored (p < 0.05). In conclusion, these results demonstrated that moisturizer containing ceramide was effective for treating skin barrier dysfunction and CAD symptoms. FAU - Jung, Ji-young AU - Jung JY AD - College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 151-742, Korea. FAU - Nam, Eui-hwa AU - Nam EH FAU - Park, Seol-hee AU - Park SH FAU - Han, Seung-hee AU - Han SH FAU - Hwang, Cheol-yong AU - Hwang CY LA - eng PT - Clinical Trial PT - Journal Article DEP - 20130621 PL - Korea (South) TA - J Vet Sci JT - Journal of veterinary science JID - 100964185 RN - 0 (Ceramides) RN - 0 (Emollients) RN - 0 (Fatty Acids, Nonesterified) RN - 0 (Ruthenium Compounds) RN - 97C5T2UQ7J (Cholesterol) RN - 97E960G9RP (ruthenium tetraoxide) SB - IM MH - Animals MH - Ceramides/*therapeutic use MH - Cholesterol/*therapeutic use MH - Dermatitis, Atopic/complications/drug therapy/physiopathology/*veterinary MH - Dog Diseases/*drug therapy/etiology/physiopathology MH - Dogs MH - Emollients/*therapeutic use MH - Epidermis/drug effects/physiopathology/ultrastructure MH - Fatty Acids, Nonesterified/*therapeutic use MH - Female MH - Male MH - Microscopy, Electron, Transmission/veterinary MH - Pruritus/drug therapy/etiology/physiopathology/veterinary MH - Republic of Korea MH - Ruthenium Compounds/chemistry MH - Water Loss, Insensible/drug effects PMC - PMC3694192 OTO - NOTNLM OT - atopic dermatitis OT - ceramide OT - dog OT - skin barrier dysfunction OT - transmission electron microscopy EDAT- 2013/07/03 06:00 MHDA- 2014/02/04 06:00 PMCR- 2013/06/01 CRDT- 2013/07/02 06:00 PHST- 2012/05/18 00:00 [received] PHST- 2012/09/30 00:00 [revised] PHST- 2012/10/23 00:00 [accepted] PHST- 2013/07/02 06:00 [entrez] PHST- 2013/07/03 06:00 [pubmed] PHST- 2014/02/04 06:00 [medline] PHST- 2013/06/01 00:00 [pmc-release] AID - 10.4142/jvs.2013.14.2.199 [doi] PST - ppublish SO - J Vet Sci. 2013;14(2):199-205. doi: 10.4142/jvs.2013.14.2.199. Epub 2013 Jun 21.